 | • レポートコード：MRC2-11QY02504 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗菌ペプチドのグローバル市場について調査・分析したレポートです。種類別（植物性抗菌ペプチド、細菌性抗菌ペプチド、動物性抗菌ペプチド、昆虫性抗菌ペプチド）市場規模、用途別（パーソナルケア・化粧品業界、ヘルスケア・製薬業界、バイオテクノロジー業界）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗菌ペプチドの競争状況、市場シェア ・世界の抗菌ペプチド市場：種類別市場規模 2015年-2020年（植物性抗菌ペプチド、細菌性抗菌ペプチド、動物性抗菌ペプチド、昆虫性抗菌ペプチド） ・世界の抗菌ペプチド市場：種類別市場規模予測 2021年-2026年（植物性抗菌ペプチド、細菌性抗菌ペプチド、動物性抗菌ペプチド、昆虫性抗菌ペプチド） ・世界の抗菌ペプチド市場：用途別市場規模 2015年-2020年（パーソナルケア・化粧品業界、ヘルスケア・製薬業界、バイオテクノロジー業界） ・世界の抗菌ペプチド市場：用途別市場規模予測 2021年-2026年（パーソナルケア・化粧品業界、ヘルスケア・製薬業界、バイオテクノロジー業界） ・北米の抗菌ペプチド市場分析：米国、カナダ ・ヨーロッパの抗菌ペプチド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗菌ペプチド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗菌ペプチド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗菌ペプチド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AnaSpec、Novozymes、Bachem、Phoenix Biotech、AMP Biotech、Shanghai Abbiochem Company、Ramamoorthy Group、Lytix Biopharma、Ai2 ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
Global anti-microbial peptides market is segmented on the basis of peptides types such as plant anti-microbial peptides, bacterial anti-microbial peptides, animal anti-microbial peptides, insect anti-microbial peptides. Among these segments, animal and plant anti-microbial peptides are capturing the major share into the market as they are easy to extract as compared with other anti-microbial peptides. Researchers are also more inclined towards animal and plant anti-microbial peptides to observe and check under clinical trials.
Market Analysis and Insights: Global Anti Microbial Peptides Market
The global Anti Microbial Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anti Microbial Peptides Scope and Market Size
Anti Microbial Peptides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti Microbial Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti Microbial Peptides market is segmented into
Plant Anti-Microbial Peptides
Bacterial Anti-Microbial Peptides
Animal Anti-Microbial Peptides
Insects Anti-Microbial Peptides
Segment by Application, the Anti Microbial Peptides market is segmented into
Personal Care and Cosmetics Industry
Healthcare & Pharmaceuticals Industry
Biotechnology Industry
Regional and Country-level Analysis
The Anti Microbial Peptides market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti Microbial Peptides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti Microbial Peptides Market Share Analysis
Anti Microbial Peptides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti Microbial Peptides business, the date to enter into the Anti Microbial Peptides market, Anti Microbial Peptides product introduction, recent developments, etc.
The major vendors covered:
AnaSpec
Novozymes
Bachem
Phoenix Biotech
AMP Biotech
Shanghai Abbiochem Company
Ramamoorthy Group
Lytix Biopharma
Ai2
1 Study Coverage
1.1 Anti Microbial Peptides Product Introduction
1.2 Market Segments
1.3 Key Anti Microbial Peptides Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti Microbial Peptides Market Size Growth Rate by Type
1.4.2 Plant Anti-Microbial Peptides
1.4.3 Bacterial Anti-Microbial Peptides
1.4.4 Animal Anti-Microbial Peptides
1.4.5 Insects Anti-Microbial Peptides
1.5 Market by Application
1.5.1 Global Anti Microbial Peptides Market Size Growth Rate by Application
1.5.2 Personal Care and Cosmetics Industry
1.5.3 Healthcare & Pharmaceuticals Industry
1.5.4 Biotechnology Industry
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti Microbial Peptides Market Size, Estimates and Forecasts
2.1.1 Global Anti Microbial Peptides Revenue 2015-2026
2.1.2 Global Anti Microbial Peptides Sales 2015-2026
2.2 Global Anti Microbial Peptides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti Microbial Peptides Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti Microbial Peptides Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti Microbial Peptides Competitor Landscape by Players
3.1 Anti Microbial Peptides Sales by Manufacturers
3.1.1 Anti Microbial Peptides Sales by Manufacturers (2015-2020)
3.1.2 Anti Microbial Peptides Sales Market Share by Manufacturers (2015-2020)
3.2 Anti Microbial Peptides Revenue by Manufacturers
3.2.1 Anti Microbial Peptides Revenue by Manufacturers (2015-2020)
3.2.2 Anti Microbial Peptides Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti Microbial Peptides Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti Microbial Peptides Revenue in 2019
3.2.5 Global Anti Microbial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti Microbial Peptides Price by Manufacturers
3.4 Anti Microbial Peptides Manufacturing Base Distribution, Product Types
3.4.1 Anti Microbial Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti Microbial Peptides Product Type
3.4.3 Date of International Manufacturers Enter into Anti Microbial Peptides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti Microbial Peptides Market Size by Type (2015-2020)
4.1.1 Global Anti Microbial Peptides Sales by Type (2015-2020)
4.1.2 Global Anti Microbial Peptides Revenue by Type (2015-2020)
4.1.3 Anti Microbial Peptides Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti Microbial Peptides Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti Microbial Peptides Sales Forecast by Type (2021-2026)
4.2.2 Global Anti Microbial Peptides Revenue Forecast by Type (2021-2026)
4.2.3 Anti Microbial Peptides Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti Microbial Peptides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti Microbial Peptides Market Size by Application (2015-2020)
5.1.1 Global Anti Microbial Peptides Sales by Application (2015-2020)
5.1.2 Global Anti Microbial Peptides Revenue by Application (2015-2020)
5.1.3 Anti Microbial Peptides Price by Application (2015-2020)
5.2 Anti Microbial Peptides Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti Microbial Peptides Sales Forecast by Application (2021-2026)
5.2.2 Global Anti Microbial Peptides Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti Microbial Peptides Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti Microbial Peptides by Country
6.1.1 North America Anti Microbial Peptides Sales by Country
6.1.2 North America Anti Microbial Peptides Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti Microbial Peptides Market Facts & Figures by Type
6.3 North America Anti Microbial Peptides Market Facts & Figures by Application
7 Europe
7.1 Europe Anti Microbial Peptides by Country
7.1.1 Europe Anti Microbial Peptides Sales by Country
7.1.2 Europe Anti Microbial Peptides Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti Microbial Peptides Market Facts & Figures by Type
7.3 Europe Anti Microbial Peptides Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti Microbial Peptides by Region
8.1.1 Asia Pacific Anti Microbial Peptides Sales by Region
8.1.2 Asia Pacific Anti Microbial Peptides Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti Microbial Peptides Market Facts & Figures by Type
8.3 Asia Pacific Anti Microbial Peptides Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti Microbial Peptides by Country
9.1.1 Latin America Anti Microbial Peptides Sales by Country
9.1.2 Latin America Anti Microbial Peptides Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti Microbial Peptides Market Facts & Figures by Type
9.3 Central & South America Anti Microbial Peptides Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti Microbial Peptides by Country
10.1.1 Middle East and Africa Anti Microbial Peptides Sales by Country
10.1.2 Middle East and Africa Anti Microbial Peptides Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti Microbial Peptides Market Facts & Figures by Type
10.3 Middle East and Africa Anti Microbial Peptides Market Facts & Figures by Application
11 Company Profiles
11.1 AnaSpec
11.1.1 AnaSpec Corporation Information
11.1.2 AnaSpec Description and Business Overview
11.1.3 AnaSpec Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AnaSpec Anti Microbial Peptides Products Offered
11.1.5 AnaSpec Related Developments
11.2 Novozymes
11.2.1 Novozymes Corporation Information
11.2.2 Novozymes Description and Business Overview
11.2.3 Novozymes Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novozymes Anti Microbial Peptides Products Offered
11.2.5 Novozymes Related Developments
11.3 Bachem
11.3.1 Bachem Corporation Information
11.3.2 Bachem Description and Business Overview
11.3.3 Bachem Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bachem Anti Microbial Peptides Products Offered
11.3.5 Bachem Related Developments
11.4 Phoenix Biotech
11.4.1 Phoenix Biotech Corporation Information
11.4.2 Phoenix Biotech Description and Business Overview
11.4.3 Phoenix Biotech Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Phoenix Biotech Anti Microbial Peptides Products Offered
11.4.5 Phoenix Biotech Related Developments
11.5 AMP Biotech
11.5.1 AMP Biotech Corporation Information
11.5.2 AMP Biotech Description and Business Overview
11.5.3 AMP Biotech Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AMP Biotech Anti Microbial Peptides Products Offered
11.5.5 AMP Biotech Related Developments
11.6 Shanghai Abbiochem Company
11.6.1 Shanghai Abbiochem Company Corporation Information
11.6.2 Shanghai Abbiochem Company Description and Business Overview
11.6.3 Shanghai Abbiochem Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shanghai Abbiochem Company Anti Microbial Peptides Products Offered
11.6.5 Shanghai Abbiochem Company Related Developments
11.7 Ramamoorthy Group
11.7.1 Ramamoorthy Group Corporation Information
11.7.2 Ramamoorthy Group Description and Business Overview
11.7.3 Ramamoorthy Group Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ramamoorthy Group Anti Microbial Peptides Products Offered
11.7.5 Ramamoorthy Group Related Developments
11.8 Lytix Biopharma
11.8.1 Lytix Biopharma Corporation Information
11.8.2 Lytix Biopharma Description and Business Overview
11.8.3 Lytix Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lytix Biopharma Anti Microbial Peptides Products Offered
11.8.5 Lytix Biopharma Related Developments
11.9 Ai2
11.9.1 Ai2 Corporation Information
11.9.2 Ai2 Description and Business Overview
11.9.3 Ai2 Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ai2 Anti Microbial Peptides Products Offered
11.9.5 Ai2 Related Developments
11.1 AnaSpec
11.1.1 AnaSpec Corporation Information
11.1.2 AnaSpec Description and Business Overview
11.1.3 AnaSpec Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AnaSpec Anti Microbial Peptides Products Offered
11.1.5 AnaSpec Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti Microbial Peptides Market Estimates and Projections by Region
12.1.1 Global Anti Microbial Peptides Sales Forecast by Regions 2021-2026
12.1.2 Global Anti Microbial Peptides Revenue Forecast by Regions 2021-2026
12.2 North America Anti Microbial Peptides Market Size Forecast (2021-2026)
12.2.1 North America: Anti Microbial Peptides Sales Forecast (2021-2026)
12.2.2 North America: Anti Microbial Peptides Revenue Forecast (2021-2026)
12.2.3 North America: Anti Microbial Peptides Market Size Forecast by Country (2021-2026)
12.3 Europe Anti Microbial Peptides Market Size Forecast (2021-2026)
12.3.1 Europe: Anti Microbial Peptides Sales Forecast (2021-2026)
12.3.2 Europe: Anti Microbial Peptides Revenue Forecast (2021-2026)
12.3.3 Europe: Anti Microbial Peptides Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti Microbial Peptides Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti Microbial Peptides Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti Microbial Peptides Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti Microbial Peptides Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti Microbial Peptides Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti Microbial Peptides Sales Forecast (2021-2026)
12.5.2 Latin America: Anti Microbial Peptides Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti Microbial Peptides Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti Microbial Peptides Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti Microbial Peptides Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti Microbial Peptides Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti Microbial Peptides Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti Microbial Peptides Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti Microbial Peptides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti Microbial Peptides Market Segments
Table 2. Ranking of Global Top Anti Microbial Peptides Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti Microbial Peptides Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Plant Anti-Microbial Peptides
Table 5. Major Manufacturers of Bacterial Anti-Microbial Peptides
Table 6. Major Manufacturers of Animal Anti-Microbial Peptides
Table 7. Major Manufacturers of Insects Anti-Microbial Peptides
Table 8. Global Anti Microbial Peptides Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Anti Microbial Peptides Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Anti Microbial Peptides Sales by Regions 2015-2020 (K Units)
Table 11. Global Anti Microbial Peptides Sales Market Share by Regions (2015-2020)
Table 12. Global Anti Microbial Peptides Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Anti Microbial Peptides Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Anti Microbial Peptides Sales Share by Manufacturers (2015-2020)
Table 15. Global Anti Microbial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Anti Microbial Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Microbial Peptides as of 2019)
Table 17. Anti Microbial Peptides Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Anti Microbial Peptides Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Anti Microbial Peptides Price (2015-2020) (USD/Unit)
Table 20. Anti Microbial Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Anti Microbial Peptides Product Type
Table 22. Date of International Manufacturers Enter into Anti Microbial Peptides Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti Microbial Peptides Sales by Type (2015-2020) (K Units)
Table 25. Global Anti Microbial Peptides Sales Share by Type (2015-2020)
Table 26. Global Anti Microbial Peptides Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Anti Microbial Peptides Revenue Share by Type (2015-2020)
Table 28. Anti Microbial Peptides Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Anti Microbial Peptides Sales by Application (2015-2020) (K Units)
Table 30. Global Anti Microbial Peptides Sales Share by Application (2015-2020)
Table 31. North America Anti Microbial Peptides Sales by Country (2015-2020) (K Units)
Table 32. North America Anti Microbial Peptides Sales Market Share by Country (2015-2020)
Table 33. North America Anti Microbial Peptides Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Anti Microbial Peptides Revenue Market Share by Country (2015-2020)
Table 35. North America Anti Microbial Peptides Sales by Type (2015-2020) (K Units)
Table 36. North America Anti Microbial Peptides Sales Market Share by Type (2015-2020)
Table 37. North America Anti Microbial Peptides Sales by Application (2015-2020) (K Units)
Table 38. North America Anti Microbial Peptides Sales Market Share by Application (2015-2020)
Table 39. Europe Anti Microbial Peptides Sales by Country (2015-2020) (K Units)
Table 40. Europe Anti Microbial Peptides Sales Market Share by Country (2015-2020)
Table 41. Europe Anti Microbial Peptides Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Anti Microbial Peptides Revenue Market Share by Country (2015-2020)
Table 43. Europe Anti Microbial Peptides Sales by Type (2015-2020) (K Units)
Table 44. Europe Anti Microbial Peptides Sales Market Share by Type (2015-2020)
Table 45. Europe Anti Microbial Peptides Sales by Application (2015-2020) (K Units)
Table 46. Europe Anti Microbial Peptides Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Anti Microbial Peptides Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Anti Microbial Peptides Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Anti Microbial Peptides Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Anti Microbial Peptides Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Anti Microbial Peptides Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Anti Microbial Peptides Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Anti Microbial Peptides Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Anti Microbial Peptides Sales Market Share by Application (2015-2020)
Table 55. Latin America Anti Microbial Peptides Sales by Country (2015-2020) (K Units)
Table 56. Latin America Anti Microbial Peptides Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Anti Microbial Peptides Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Anti Microbial Peptides Revenue Market Share by Country (2015-2020)
Table 59. Latin America Anti Microbial Peptides Sales by Type (2015-2020) (K Units)
Table 60. Latin America Anti Microbial Peptides Sales Market Share by Type (2015-2020)
Table 61. Latin America Anti Microbial Peptides Sales by Application (2015-2020) (K Units)
Table 62. Latin America Anti Microbial Peptides Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Anti Microbial Peptides Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Anti Microbial Peptides Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Anti Microbial Peptides Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Anti Microbial Peptides Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Anti Microbial Peptides Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Anti Microbial Peptides Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Anti Microbial Peptides Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Anti Microbial Peptides Sales Market Share by Application (2015-2020)
Table 71. AnaSpec Corporation Information
Table 72. AnaSpec Description and Major Businesses
Table 73. AnaSpec Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. AnaSpec Product
Table 75. AnaSpec Recent Development
Table 76. Novozymes Corporation Information
Table 77. Novozymes Description and Major Businesses
Table 78. Novozymes Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Novozymes Product
Table 80. Novozymes Recent Development
Table 81. Bachem Corporation Information
Table 82. Bachem Description and Major Businesses
Table 83. Bachem Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Bachem Product
Table 85. Bachem Recent Development
Table 86. Phoenix Biotech Corporation Information
Table 87. Phoenix Biotech Description and Major Businesses
Table 88. Phoenix Biotech Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Phoenix Biotech Product
Table 90. Phoenix Biotech Recent Development
Table 91. AMP Biotech Corporation Information
Table 92. AMP Biotech Description and Major Businesses
Table 93. AMP Biotech Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. AMP Biotech Product
Table 95. AMP Biotech Recent Development
Table 96. Shanghai Abbiochem Company Corporation Information
Table 97. Shanghai Abbiochem Company Description and Major Businesses
Table 98. Shanghai Abbiochem Company Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Shanghai Abbiochem Company Product
Table 100. Shanghai Abbiochem Company Recent Development
Table 101. Ramamoorthy Group Corporation Information
Table 102. Ramamoorthy Group Description and Major Businesses
Table 103. Ramamoorthy Group Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Ramamoorthy Group Product
Table 105. Ramamoorthy Group Recent Development
Table 106. Lytix Biopharma Corporation Information
Table 107. Lytix Biopharma Description and Major Businesses
Table 108. Lytix Biopharma Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Lytix Biopharma Product
Table 110. Lytix Biopharma Recent Development
Table 111. Ai2 Corporation Information
Table 112. Ai2 Description and Major Businesses
Table 113. Ai2 Anti Microbial Peptides Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Ai2 Product
Table 115. Ai2 Recent Development
Table 116. Global Anti Microbial Peptides Sales Forecast by Regions (2021-2026) (K Units)
Table 117. Global Anti Microbial Peptides Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Anti Microbial Peptides Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Anti Microbial Peptides Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Anti Microbial Peptides Sales Forecast by Country (2021-2026) (K Units)
Table 121. North America: Anti Microbial Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Anti Microbial Peptides Sales Forecast by Country (2021-2026) (K Units)
Table 123. Europe: Anti Microbial Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Anti Microbial Peptides Sales Forecast by Region (2021-2026) (K Units)
Table 125. Asia Pacific: Anti Microbial Peptides Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Anti Microbial Peptides Sales Forecast by Country (2021-2026) (K Units)
Table 127. Latin America: Anti Microbial Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Anti Microbial Peptides Sales Forecast by Country (2021-2026) (K Units)
Table 129. Middle East and Africa: Anti Microbial Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Anti Microbial Peptides Players
Table 134. Anti Microbial Peptides Customers List
Table 135. Anti Microbial Peptides Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti Microbial Peptides Product Picture
Figure 2. Global Anti Microbial Peptides Sales Market Share by Type in 2020 & 2026
Figure 3. Plant Anti-Microbial Peptides Product Picture
Figure 4. Bacterial Anti-Microbial Peptides Product Picture
Figure 5. Animal Anti-Microbial Peptides Product Picture
Figure 6. Insects Anti-Microbial Peptides Product Picture
Figure 7. Global Anti Microbial Peptides Sales Market Share by Application in 2020 & 2026
Figure 8. Personal Care and Cosmetics Industry
Figure 9. Healthcare & Pharmaceuticals Industry
Figure 10. Biotechnology Industry
Figure 11. Anti Microbial Peptides Report Years Considered
Figure 12. Global Anti Microbial Peptides Market Size 2015-2026 (US$ Million)
Figure 13. Global Anti Microbial Peptides Sales 2015-2026 (K Units)
Figure 14. Global Anti Microbial Peptides Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Anti Microbial Peptides Sales Market Share by Region (2015-2020)
Figure 16. Global Anti Microbial Peptides Sales Market Share by Region in 2019
Figure 17. Global Anti Microbial Peptides Revenue Market Share by Region (2015-2020)
Figure 18. Global Anti Microbial Peptides Revenue Market Share by Region in 2019
Figure 19. Global Anti Microbial Peptides Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Anti Microbial Peptides Revenue in 2019
Figure 21. Anti Microbial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Anti Microbial Peptides Sales Market Share by Type (2015-2020)
Figure 23. Global Anti Microbial Peptides Sales Market Share by Type in 2019
Figure 24. Global Anti Microbial Peptides Revenue Market Share by Type (2015-2020)
Figure 25. Global Anti Microbial Peptides Revenue Market Share by Type in 2019
Figure 26. Global Anti Microbial Peptides Market Share by Price Range (2015-2020)
Figure 27. Global Anti Microbial Peptides Sales Market Share by Application (2015-2020)
Figure 28. Global Anti Microbial Peptides Sales Market Share by Application in 2019
Figure 29. Global Anti Microbial Peptides Revenue Market Share by Application (2015-2020)
Figure 30. Global Anti Microbial Peptides Revenue Market Share by Application in 2019
Figure 31. North America Anti Microbial Peptides Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Anti Microbial Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Anti Microbial Peptides Sales Market Share by Country in 2019
Figure 34. North America Anti Microbial Peptides Revenue Market Share by Country in 2019
Figure 35. U.S. Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Anti Microbial Peptides Market Share by Type in 2019
Figure 40. North America Anti Microbial Peptides Market Share by Application in 2019
Figure 41. Europe Anti Microbial Peptides Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Anti Microbial Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Anti Microbial Peptides Sales Market Share by Country in 2019
Figure 44. Europe Anti Microbial Peptides Revenue Market Share by Country in 2019
Figure 45. Germany Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Anti Microbial Peptides Market Share by Type in 2019
Figure 56. Europe Anti Microbial Peptides Market Share by Application in 2019
Figure 57. Asia Pacific Anti Microbial Peptides Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Anti Microbial Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Anti Microbial Peptides Sales Market Share by Region in 2019
Figure 60. Asia Pacific Anti Microbial Peptides Revenue Market Share by Region in 2019
Figure 61. China Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Anti Microbial Peptides Market Share by Type in 2019
Figure 84. Asia Pacific Anti Microbial Peptides Market Share by Application in 2019
Figure 85. Latin America Anti Microbial Peptides Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Anti Microbial Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Anti Microbial Peptides Sales Market Share by Country in 2019
Figure 88. Latin America Anti Microbial Peptides Revenue Market Share by Country in 2019
Figure 89. Mexico Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Anti Microbial Peptides Market Share by Type in 2019
Figure 96. Latin America Anti Microbial Peptides Market Share by Application in 2019
Figure 97. Middle East and Africa Anti Microbial Peptides Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Anti Microbial Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Anti Microbial Peptides Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Anti Microbial Peptides Revenue Market Share by Country in 2019
Figure 101. Turkey Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Anti Microbial Peptides Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Anti Microbial Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Anti Microbial Peptides Market Share by Type in 2019
Figure 108. Middle East and Africa Anti Microbial Peptides Market Share by Application in 2019
Figure 109. North America Anti Microbial Peptides Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Anti Microbial Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Anti Microbial Peptides Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Anti Microbial Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Anti Microbial Peptides Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Anti Microbial Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Anti Microbial Peptides Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Anti Microbial Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Anti Microbial Peptides Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Anti Microbial Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
抗菌/抗真菌検査の世界市場（～2026年） Market Analysis and Insights: Global Anti-microbial/Anti-fungal Tests Market The global Anti-microbial/Anti-fungal Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-microbial/Anti-fungal Tests Scope and Market…- 抗炎症ペプチドの世界市場（～2026年） Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal's skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and…
- 抗菌包装材料の世界市場（～2026年） The preference for eco-friendly packaging materials such as biodegradable plastics is increasing because they exhibit a non-toxic effect on the environment when compared to conventional plastics. Microorganisms can easily decompose biodegradable plastics. The anti-microbial packaging materials mark…
- 微生物燃料電池（MFC）の世界市場（～2026年） Microbial Fuel Cell (MFC) is a bio-electrochemical system that produces electric current by using bacteria. MFC is essentially a device that converts chemical energy into electrical energy by using bacteria or microorganisms. MFC has gained attention due to its capability to produce electricity from…
- 組換えペプチドの世界市場（～2026年） Market Analysis and Insights: Global Recombinant Peptides Market The global Recombinant Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Recombinant Peptides Scope and Market Size Recombinant Peptides market is…